ISSN 2639-9431
Vol. 1, Issue 1, 2018April 17, 2018 EDT
Improving Innovation in Nano-Healthcare Funding
Improving Innovation in Nano-Healthcare Funding
Articles in Vol. 1, Issue 1, 2018
Vol. 1, Issue 1, 2018
- A porcine model of complement activation-related pseudoallergy to nano-pharmaceuticals: Pros and cons of translation to a preclinical safety testJános SzebeniRudolf UrbanicsLászló DézsiPéter Bedőcs
- Origins to Outcomes: A Role for Extracellular Vesicles in Precision MedicineAdriele Prina-MelloCiaran Magus MaguireJohn Savage
- Discrepancies in the in vitro and in vivo role of scavenger receptors in clearance of nanoparticles by Kupffer cellsDmitri SimbergErnest GromanGuankui Wang
- Immunocompatibility of Rad-PC-Rad liposomes in vitro, based on human complement activation and cytokine releaseBert MüllerSofiya MatviykivGabriela GerganovaTamás MészárosGergely Tibor KozmaUte MettalFrederik NeuhausTakashi IshikawaJános SzebeniAndreas Zumbuehl
- Improving Innovation in Nano-Healthcare FundingMike Eaton
- Balancing Interests of Science, Scientists, and the Publishing BusinessLajos P Balogh
- The Story of Precision Nanomedicine – the JournalLajos Balogh
Eaton, Mike. 2018. “Improving Innovation in Nano-Healthcare Funding.” Precision Nanomedicine 1 (1): 15–17. https://doi.org/10.29016/180108.1.